Medicines optimisation in older people: Taking age and sex into account

Maturitas

Volumn 93, Issue , 2016, Pages 114-120

  Lucas, Catherine ^a   Byles, Julie ^a   Martin, Jennifer H ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

65 and over; Aged; Drug interactions; Drug prescriptions; Female; Inappropriate prescribing; Polypharmacy

Indexed keywords

PRESCRIPTION DRUG;

ADVERSE DRUG REACTION; AGE; DECISION SUPPORT SYSTEM; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG INTERACTION; DRUG METABOLISM; HUMAN; MEDICATION COMPLIANCE; PHARMACODYNAMIC PARAMETERS; PHARMACOKINETIC PARAMETERS; PRESCRIPTION; REVIEW; SEX DIFFERENCE;

EID: 84992450910     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2016.06.021     Document Type: Review

References (28)

1. [1] European Medicines Agency (EMEA). ICH Topic E 7. Note for Guidance on Studies in Support of Special Populations: Geriatrics. EMA/CPMP/ICH/379/951994 May 2016. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002875.pdf.
2. [2] Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev., 4, 2015, 1.
3. [3] Meibohm, B., Beierle, I., Derendorf, H., How important are gender differences in pharmacokinetics?. Clin. Pharmacokinet. 41:5 (2002), 329–342.
4. [4] Barry, P.P., Gender as a factor in treating the elderly. NIDA Res. Monogr. Ser. 65 (1986), 65–69.
5. [5] Braude, M.C., Drugs and drug interactions in the elderly woman. NIDA Res. Monogr. Ser. 65 (1986), 58–64.
6. [6] Wright, D.F., Begg, E.J., The ‘apparent clearance' of free phenytoin in elderly vs younger adults. Br. J. Clin. Pharmacol. 70:1 (2010), 132–138.
7. [7] Relling, M.V., Lin, J.S., Ayers, G.D., Evans, W.E., Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin. Pharmacol. Ther. 52:6 (1992), 643–658.
8. [8] Harris, R.Z., Benet, L.Z., Schwartz, J.B., Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:2 (1995), 222–239.
9. [9] Xie, T., Ho, S.L., Ramsden, D., Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol. 56:1 (1999), 31–38.
10. [10] Cockcroft, D.W., Gault, M.H., Prediction of creatinine clearance from serum creatinine. Nephron 16:1 (1976), 31–41.
11. [11] Martin, J.H., Fay, M.F., Ungerer, J.P., eGFR-use beyond the evidence. Med. J. Aust. 190:4 (2009), 197–199.
12. [12] Venturini, C.D., Engroff, P., Ely, L.S., De Araujo Zago, L.F., Schroeter, G., Gomes, I., et al. Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics 66:11 (2011), 1867–1872.
13. [13] Rivera, R., Antognini, J.F., Perioperative drug therapy in elderly patients. Anesthesiology 110:5 (2009), 1176–1181.
14. [14] Mannesse, C.K., Derkx, F.H., De Ridder, M.A., Man in ‘T Veld, A.J., Van Der Cammen, T.J., Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 29:1 (2000), 35–39.
15. [15] Qato, D.M., Alexander, G.C., Conti, R.M., Johnson, M., Schumm, P., Lindau, S., T: Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA: J. Am. Med. Assoc. 300:24 (2008), 2867–2878.
16. [16] Scott, I.A., Hilmer, S.N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern. Med. 175:5 (2015), 827–834.
17. [17] Hofer-Dueckelmann, C., Prinz, E., Beindl, W., Szymanski, J., Fellhofer, G., Pichler, M., et al. Adverse drug reactions (ADRs) associated with hospital admissions—elderly female patients are at highest risk. Int. J. Clin. Pharmacol. Ther. 49:10 (2011), 577–586.
18. [18] Schwartz, J.B., The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin. Pharmacol. Ther. 82:1 (2007), 87–96.
19. [19] Kando, J.C., Yonkers, K.A., Cole, J.O., Gender as a risk factor for adverse events to medications. Drugs 50:1 (1995), 1–6.
20. [20] Hubbard, R.E., Peel, N.M., Scott, I.A., Martin, J.H., Smith, A., Pillans, P.I., et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med. J. Aust. 202:7 (2015), 373–377.
21. [21] Parkinson, L., Magin, P.J., Thomson, A., Byles, J.E., Caughey, G.E., Etherton-Beer, C., et al. Anticholinergic burden in older women: not seeing the wood for the trees?. Med. J. Aust. 202:2 (2015), 91–94.
22. [22] Baker, D.W., Wolf, M.S., Feinglass, J., Thompson, J.A., Gazmararian, J.A., Huang, J., Health literacy and mortality among elderly persons. Arch. Intern. Med. 167:14 (2007), 1503–1509.
23. [23] Scott, I.A., Gray, L.C., Martin, J.H., Pillans, P.I., Mitchell, C.A., Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid. Based Med. 18:4 (2013), 121–124.
24. [24] American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 60 (4) (2012) 616–631.
25. [25] Gallagher, P.F., O'connor, M.N., O'mahony, D., Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin. Pharmacol. Ther. 89:6 (2011), 845–854.
26. [26] Patterson, Susan M., Cadogan, Cathal A., Kerse, N., Cardwell, Chris R., Bradley, Marie C., Ryan, C., et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst. Rev. [Internet](10), 2014.
27. [27] Christensen, M., Lundh, A., Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst. Rev. [Internet].(2), 2016.
28. [28] Alldred, D.P., Kennedy, M.C., Hughes, C., Chen, T.F., Miller, P., Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst. Rev., 2, 2016, CD009095.